Questions over safety and effectiveness of new Alzheimer’s drug

Investigation raises concerns about excess deaths, missing safety data, questionable effectiveness, and financial ties among expert advisors  7 of the 8 doctors on review panel received direct payments from drug companies The safety and effectiveness of donanemab - an Alzheimer’s drug recently approved by the US Food & Drug Administration ...

2024-09-26T08:50:50+00:0026 September 2024|Press release, The BMJ|

Remote video consultations linked to reduced depression and anxiety

Effect size is small, but improvement still meaningful given high levels of these disorders, say researchers Remote video consultations between patients and mental health specialists show a small but significant improvement on symptoms of depression and anxiety, finds a trial published by The BMJ today. Although the effect size is small, the ...

2024-09-26T08:48:31+00:0026 September 2024|Press release, The BMJ|

Triptans more effective than newer, more expensive migraine drugs

The most effective triptans should be promoted globally and guidelines updated accordingly, say researchers Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published by The BMJ today. Triptans work by narrowing blood vessels in the brain and preventing ...

2024-09-19T09:16:05+00:0019 September 2024|Press release, The BMJ|

Shorter-course radiation better option for breast cancer patients than conventional schedule

Although survival and recurrence were similar, this approach is safer, more convenient for patients, and less costly, say researchers Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects and improves quality of life compared with a ...

2024-09-12T15:18:21+00:0012 September 2024|Press release, The BMJ|

One dose of smallpox vaccine moderately effective in preventing mpox infection

Vaccine should be made available to communities at risk, say researchers One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a study published by The BMJ today. With mpox infections rising again across the ...

2024-09-12T15:15:58+00:0012 September 2024|Press release, The BMJ|

Prostate cancer rates across Europe since 1980 “indicative of overdiagnosis” say experts

Findings reinforce need for carefully planned screening programmes to minimise harms of overdiagnosis Rates of prostate cancer across Europe since 1980 are “indicative of overdiagnosis”, say researchers in a study published by The BMJ today. Overdiagnosis refers to the detection of harmless cancers that are unlikely to cause symptoms or death during ...

2024-09-05T09:09:56+00:005 September 2024|Press release, The BMJ|
Go to Top